dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Rubio Pérez, Carlota |
dc.contributor.author | Planas Rigol, Ester |
dc.contributor.author | Trincado, Juan L. |
dc.contributor.author | Bonfill Teixidor, Ester |
dc.contributor.author | Arias Piñeiro, Alexandra |
dc.contributor.author | Marchese, Domenica |
dc.contributor.author | Iurlaro, Raffaella |
dc.contributor.author | Martínez Ricarte, Francisco Ramón |
dc.contributor.author | Escudero Monreal, Laura |
dc.contributor.author | Cordero Asanza, Esteban Xavier |
dc.contributor.author | Cicuendez López Ocaña, Marta |
dc.contributor.author | Nuciforo, Paolo Giovanni |
dc.contributor.author | Sahuquillo Barris, Joan |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Seoane Suarez, Joan |
dc.contributor.author | Serna, Garazi |
dc.date.accessioned | 2021-07-15T12:22:26Z |
dc.date.available | 2021-07-15T12:22:26Z |
dc.date.issued | 2021-03-08 |
dc.identifier.citation | Rubio-Perez C, Planas-Rigol E, Trincado JL, Bonfill-Teixidor E, Arias A, Marchese D, et al. Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment. Nat Commun. 2021 Mar 8;12(1):1503. |
dc.identifier.issn | 2041-1723 |
dc.identifier.uri | https://hdl.handle.net/11351/6171 |
dc.description | Microambient del càncer; Immunologia tumoral |
dc.description.sponsorship | The study was undertaken with the support of the Fundación Asociación Española contra el Cáncer (AECC), FERO (EDM), Ramón Areces Foundation, Cellex Foundation, BBVA (CAIMI), the ISCIII, FIS (PI16/01278), the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE), the Juan de la Cierva formación fellowship (C.R.-P. and L.E.), Sara Borrell fellowship (E.P-R.). We acknowledge support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Program/Generalitat de Catalunya. We also acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, and the Co-financing by the Spanish Ministry of Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014–2020 Smart Growth Operating Program. |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Nature Communications;12(1) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Cervell - Tumors |
dc.subject | Càncer - Immunoteràpia |
dc.subject | Metàstasi |
dc.subject.mesh | Brain Neoplasms |
dc.subject.mesh | Antineoplastic Agents, Immunological |
dc.subject.mesh | Neoplasm Metastasis |
dc.title | Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41467-021-21789-x |
dc.subject.decs | neoplasias cerebrales |
dc.subject.decs | inmunoterapia antineoplásica |
dc.subject.decs | metástasis neoplásica |
dc.relation.publishversion | https://www.nature.com/articles/s41467-021-21789-x |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Rubio-Perez C, Planas-Rigol E, Bonfill-Teixidor E, Arias A, Serna G, Iurlaro R, Escudero L, Nuciforo P] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Trincado JL] CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain. [Marchese D] CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. [Martínez-Ricarte F, Cordero E, Cicuendez M, Sahuquillo J] Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Tabernero J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBERONC, Barcelona, Spain. [Seoane J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBERONC, Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain |
dc.identifier.pmid | 33686071 |
dc.identifier.wos | 000627442600001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F01278 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2017-89109-P |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |